Company news

Hitgen Inc. Class A (SSE:688222) news

Hitgen Inc. Class A news releases on 6ix. Latest, Sep 29, 2026: "HitGen Inc."Announcement on Issuance Results of the 1st Tranche of Sci-Tech Innovation Bonds…

Hitgen Inc. Class A (SSE:688222) news

Press releases & updates

"HitGen Inc."Announcement on Issuance Results of the 1st Tranche of Sci-Tech Innovation Bonds for 2026

"HitGen Inc."Announcement on Vesting Results for the First Vesting Period under the 2025 Restricted Share Incentive Plan and Listing of Shares

"HitGen Inc."Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional Investors

"HitGen Inc."Announcement on Shareholding Reduction Plan of Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)

"HitGen Inc."Announcement on Resolutions of the 9th Meeting of the 3rd Board of Directors

"HitGen Inc."Announcement on Results of Shareholding Reduction by Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)

"HitGen Inc."Announcement on Developing Certain Corporate Governance Policies

"HitGen Inc."Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5%

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Announcement on Implementation of Dividend Distribution for 2025

Notice on Convening the 2nd Extraordinary General Meeting in 2026

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on Progress in Capital Increase in Joint-stock Companies and Completion of Industrial and Commercial Change Registration

Announcement on Shareholding Reduction Plan for Shareholders

ESG | HitGen Releases 2025 Sustainability Report

Announcement on Resolutions of the 6th Meeting of the 3rd Board of Directors

Announcement on Shareholding Reduction Results for Shareholder Shenzhen Juntian Investment Enterprise (Limited Partnership)

Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Announcement on Preliminary Earnings Estimate for 2025

Notice on Convening the 1st Extraordinary General Meeting in 2026

Announcement on Capital Increase in a Joint-stock Company and Related Party Transactions

Announcement on the Completion and Results of the Share Increase Plan by Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership), a Person Acting in Concert of the Controlling Shareholder and the Actual Controller

Announcement on Expected Increase in Performance for 2025

Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan

Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership Plan

Announcement on Outward Investment

HitGen Submits Commitment Letter to Science Based Targets initiative (SBTi)

Announcement on Results of Shareholding Reduction by Shareholder Lhasa Economic and Technological Development Zone Huabo Medical Equipment Co., Ltd.

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

Announcement on Convening the Q3 2025 Performance Briefing

Report for Q3 2025

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor

Board of Supervisors' Verification Opinions and Publicity Explanation on List of Proposed Incentive Objects in 2025 Restricted Stock Incentive Plan

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale

Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0

Announcement on Abnormal Fluctuations in Stock Trading

ESG | HitGen Releases Its Inaugural Sustainability Report

Indicative Announcement on Terminating Major Asset Restructuring

Indicative Announcement on Changes in Equity of Shareholder with Over 5% Shares and Results of Shareholding Reduction

Announcement on Result of Share Reduction by Shareholder Huabo Medical Device Co., Ltd., Lhasa Economic and Technological Development Zone

Announcement on Providing Guarantee for Wholly-owned Subsidiary

Announcement on Implementation of Dividend Distribution for 2024

Announcement on Progress in Planning Major Asset Restructuring

Indicative Announcement on Equity Change of Shareholder Anji Dongfang Jiayu Enterprise Management Partnership (Limited Partnership) with Over 5% Shares Reaching 1% Scale

Indicative Announcement on Postponing Term Change of the Board of Directors and the Board of Supervisors and Proposing Resignation by Independent Director upon Expiration of Term

Announcement on Share Increase Plan of Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership)

2024 Annual Report

Indicative Announcement on Planning Major Asset Restructuring and Signing Letter of Intent for Equity Acquisition